Development of a fluorescence-based assay to screen antiviral drugs against Kaposi's sarcoma associated herpesvirus.
about
Targeting KSHV/HHV-8 latency with COX-2 selective inhibitor nimesulide: a potential chemotherapeutic modality for primary effusion lymphomaUpdate on HHV-8-Associated MalignanciesAltering the Anti-inflammatory Lipoxin Microenvironment: a New Insight into Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis.The Kaposi's sarcoma-associated herpesvirus (KSHV)-induced 5-lipoxygenase-leukotriene B4 cascade plays key roles in KSHV latency, monocyte recruitment, and lipogenesis.Glutamate secretion and metabotropic glutamate receptor 1 expression during Kaposi's sarcoma-associated herpesvirus infection promotes cell proliferation.Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.The open chromatin landscape of Kaposi's sarcoma-associated herpesvirusKaposi's sarcoma-associated herpesvirus-induced angiogenin plays roles in latency via the phospholipase C gamma pathway: blocking angiogenin inhibits latent gene expression and induces the lytic cycle.Kaposi's sarcoma-associated herpesvirus latency in endothelial and B cells activates gamma interferon-inducible protein 16-mediated inflammasomes.
P2860
Q21135231-2DB8B6CE-FE18-4448-9FCE-947C5AE818E6Q33814153-18A96278-A179-49E2-9F50-C148E24A2E0EQ34541350-9A6D9D56-009C-4ECD-A4CF-A90C6308AF9FQ35066362-167BCE73-5C0A-4BC8-8DBF-4B4AA5BE61D7Q35315503-DDA4015C-56D3-4403-888A-3CE65819EA82Q35861265-A2E0E89B-2D26-4180-BA5B-846EE26BAD22Q37252776-CA27838F-DD96-42CB-A879-D42C71900ACAQ39611761-61608172-C498-4D49-9A2F-A354CBE265E7Q39792755-EF2978CF-6BDE-4D99-B06A-F15CADD1E9C2
P2860
Development of a fluorescence-based assay to screen antiviral drugs against Kaposi's sarcoma associated herpesvirus.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Development of a fluorescence- ...... arcoma associated herpesvirus.
@ast
Development of a fluorescence- ...... arcoma associated herpesvirus.
@en
type
label
Development of a fluorescence- ...... arcoma associated herpesvirus.
@ast
Development of a fluorescence- ...... arcoma associated herpesvirus.
@en
prefLabel
Development of a fluorescence- ...... arcoma associated herpesvirus.
@ast
Development of a fluorescence- ...... arcoma associated herpesvirus.
@en
P2093
P2860
P1476
Development of a fluorescence- ...... arcoma associated herpesvirus.
@en
P2093
Chelsey Hilscher
David J Kroll
Dirk P Dittmer
Djaja D Soejarto
Pius Piskaut
Ryan J Case
Shou-Jian Gao
Tamara K Nun
Teatulohi Matainaho
P2860
P304
P356
10.1158/1535-7163.MCT-07-0108
P577
2007-08-01T00:00:00Z